Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Ömer Faruk Turan"'
Autor:
Sümeyye Koç, Sedat Şen, Yüksel Terzi, Ferah Kızılay, Serkan Demir, Dürdane Bekar Aksoy, Fatma Kurtuluş, Nuray Bilge, Egemen Idilman, Cihat Uzunköprü, Serdal Güngör, Vedat Çilingir, Özlem Ethemoğlu, Cavit Boz, Haluk Gümüş, Ahmet Kasım Kılıç, Ayşin Kısabay, Levent Sinan Bir, Ömer Faruk Turan, Aysun Soysal, Mesrure Köseoğlu, Gülnur Tekgöl Uzuner, Hasan Bayındır, Sibel Canbaz Kabay, Mustafa Çam, Vildan Yayla, Hüseyin Tan, Abdülcemal Özcan, Özlem Taşkapıoğlu, Muammer Korkmaz, Yusuf Tamam, Yılmaz İnanç, Hüsnü Efendi, Dilcan Kotan, Mehmet Fatih Yetkin, Adnan Burak Bilgiç, Hikmet Saçmacı, Serpil Demirci, Yahya Çelik, Turan Poyraz, Murat Terzi
Publikováno v:
Balkan Medical Journal, Vol 41, Iss 4, Pp 272-279 (2024)
Background: Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and dem
Externí odkaz:
https://doaj.org/article/71299fcaf9b74494b8e92b417d48bda4
Publikováno v:
Türk Nöroloji Dergisi, Vol 29, Iss 4, Pp 282-286 (2023)
Objective: To evaluate the peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell–inner plexiform layer thickness (GC–IPL) in patients with multiple sclerosis (MS) by sector and quadrant. Materials and Methods: Seventy-eight eyes of 39
Externí odkaz:
https://doaj.org/article/59d56d2e424d40caa2541e4437293f62
Publikováno v:
Turkish Journal of Internal Medicine, Vol 2, Iss 4, Pp 105-112 (2020)
Introduction: Multiple Sclerosis (MS) is a multifactorial, immune-mediated disorder that occurs in genetically predisposed people. Vitamin D might be an important environmental factor in the development and prevention of MS disease. We aimed to inves
Externí odkaz:
https://doaj.org/article/574d1d51413d4868b1b9d2751decadd3
Autor:
Ali Özhan Sıvacı, Aylin Bican Demir, Ömer Faruk Turan, Özlem Taşkapılıoğlu, İbrahim Bora, Gökhan Ocakoğlu
Publikováno v:
Türk Uyku Tıbbı Dergisi, Vol 5, Iss 3, Pp 91-98 (2018)
Objective: To investigate fatigue and sleep disorders based on demographic, clinical and polysomnographic data and show their effects on the quality of life in multiple sclerosis (MS) patients. Materials and Methods: Thirty MS patients were enrolled
Externí odkaz:
https://doaj.org/article/dcd7eb69b3b44a959560b29322479d27
Autor:
Özlem Taşkapılıoğlu, Deniz Kamacı Şener, Aslı Bahar Turan, Şükran Yurtoğulları, Ahmet Tütüncü, Sümeyye Güllülü, Gökhan Ocakoğlu, Ömer Faruk Turan
Publikováno v:
Türk Nöroloji Dergisi, Vol 18, Iss 2, Pp 62-66 (2012)
OBJECTIVE: To investigate the secondary progressive multiple sclerosis (SPMS) patients treated with mitoxantrone (MIT) and discuss the effectiveness and side effects of MIT. METHODS: We retrospectively investigated 48 SPMS patients who completed or
Externí odkaz:
https://doaj.org/article/f7948879c6164b12b0ecf0e2e5ce7191
Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
Publikováno v:
Türk Nöroloji Dergisi, Vol 18, Iss 1, Pp 17-20 (2012)
OBJECTIVE: Glatiramer acetate (GA) has been shown to reduce the number of relapses and improve outcomes in relapsing-remitting multiple sclerosis (RRMS) patients. The aim of this study is to investigate the efficacy and side effects of GA in RRMS pat
Externí odkaz:
https://doaj.org/article/4e359209409c421789e85b5ddaa2965d
Autor:
Taşkıran, Esra, Terzi, Murat, Helvacı, Elif Merve, Eser, Meltem Zeycan, Avcı, Bahattin, Ömer Faruk, Turan, Yetkin, Mehmet Fatih, Çilingir, Vedat, Bir, Levent Sinan, Kabay, Sibel Canbaz, Bilge, Nuray, Poyraz, Turan, Demir, Caner Feyzi, Dündar, Dilcan Kotan, Ocak, Özgül, Çam, Mustafa, Mavioğlu, Hatice, Altun, Yaşar, Karaibrahimoğlu, Adnan
Publikováno v:
In Multiple Sclerosis and Related Disorders March 2024 83
Autor:
MERYEM ASLI TUNCER, MURAT KÜRTÜNCÜ, MURAT TERZİ, UĞUR UYGUNOĞLU, CANSU GÖNCÜOĞLU, AYŞE NUR YÜCEYAR, ÖZGÜL EKMEKCİ, RECAİ TÜRKOĞLU, AYSUN SOYSAL, MESRURE KÖSEOĞLU, CAVİT BOZ, YEŞİM BECKMANN, ÖMER FARUK TURAN, DURUHAN MELTEM DEMİRKIRAN, FİRDEVS GÜLŞEN AKMAN
Publikováno v:
Turkish Journal of Medical Sciences. 53:323-332
Background/aim: During multiple sclerosis (MS) treatment different modes of action such as lateral (interferon beta to glatiramer acetate or glatiramer acetate to interferon beta) or vertical (interferon beta/glatiramer acetate to fingolimod) drug sw
Publikováno v:
The Journal of Academic Social Resources. :2131-2138
Autor:
Melih Tütüncü, Serkan Demir, Gökhan Arslan, Öykü Dinç, Sedat Şen, Tuncay Gündüz, Cihat Uzunköprü, Haluk Gümüş, Mesude Tütüncü, Rüveyda Akçin, Serkan Özakbaş, Mesrure Köseoğlu, Sena Destan Bünül, Ozan Gezen, Damla Çetinkaya Tezer, Cavid Baba, Pınar Acar Özen, Rabia Koç, Tuğrul Elverdi, Uğur Uygunoğlu, Murat Kürtüncü, Yeşim Beckmann, İpek Güngör Doğan, Ömer Faruk Turan, Cavit Boz, Murat Terzi, Asli Tuncer, Sabahattin Saip, Rana Karabudak, Bekir Kocazeybek, Hüsnü Efendi, Uğur Bilge, Aksel Siva
Background: COVID-19 vaccines are recommended for people with multiple sclerosis (pwMS). Adequate humoral responses are obtained in pwMS receiving disease-modifying therapies (DMTs) after vaccination, with the exception of those receiving B-cell-depl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f1944fc2585d69f26fdff210c2db9d0
https://avesis.deu.edu.tr/publication/details/e5b3fb6b-a010-478f-a08d-7bdb7bdc68dd/oai
https://avesis.deu.edu.tr/publication/details/e5b3fb6b-a010-478f-a08d-7bdb7bdc68dd/oai